Treating children with recurrent respiratory papillomatosis can be very rew
arding as more information is learned about human papillomavirus. The futur
e goals are reducing the morbidity and mortality of this disease process. T
he establishment of the national recurrent respiratory papillomatosis patie
nt registry and coordinated efforts between basic scientists involved in hu
man papillomavirus research and clinicians involved in the treatment of rec
urrent respiratory papillomatosis should aid the endeavor.